semaglutide long-term safety weight loss effects of in obesity without diabetes in the SELECT trial Abstract 4134308: Re-evaluating the safety

Day 10 cultured SCD erythroblasts were treated with 75 M hemin (#51280, Sigma) (dissolved in 0.25 M NaOH then neutralized with HCL to pH7.4), 50 M dimethyl fumarate (#242926, Sigma) (dissolved in DMSO), 0.5 mM (2S)-Tetrahydro-5-oxo-2-furancarboxylic acid (TFMB-L2HG) (#SML2563, Sigma) (dissolved in DMSO), 0.5 mM S-(5-Adenosyl)-L-methionine iodide (SAM) (#A4377, Sigma) (dissolved in water), and cultured under hypoxia (1% O 2 ) using Heracell 150i incubator equipped with an Oxygen (O 2 ) sensor and Nitrogen (N2) gas supply and analyzed on day 12 of culture

doi:10.1002/ptr.5432

The result is a three-tier eligibility framework, and which tier you fall under matters less than the fact that meeting any one of them gives you the same $50 per month medication coverage

Zhang, Y., Chen, R., Jia, Y., Chen, M

Id give 10 stars if I could

semaglutide 1.0 mg (92%) and placebo (92%)